SCHEMBL4184743

SCHEMBL4184743

CS(=O)(=O)c1ccc(Cn2cc(C(=O)NCc3ccc(Cl)cc3Cl)ccc2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 3/20 0.56
GAA P10253 2/20 0.56
LMNA P02545 2/20 0.56
MAPK1 P28482 1/20 0.56
NLRP1 Q9C000 1/20 0.56
MAPK8 P45983 1/20 0.51
DDR1 Q08345 3/20 0.49
KLKB1 P03952 1/20 0.48
KLK1 P06870 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
RORC P51449 1/20 0.47
BRD4 O60885 1/20 0.45
BRD2 P25440 1/20 0.45
BRD3 Q15059 1/20 0.45
BRDT Q58F21 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4189333 0.87 LMNA (0.53) EPHX2LMNAMAPK1NLRP1MAPK8
SCHEMBL21490251 0.85 LMNA (0.68) EPHX2LMNAMAPK1NLRP1
SCHEMBL4189507 0.82 EPHX2 (0.74) EPHX2SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL13876163 0.78 EPHX2 (0.77) EPHX2SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL4199798 0.77 EPHX2 (0.67) EPHX2SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL4190539 0.76 EPHX2 (0.63) EPHX2SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL4190370 0.76 EPHX2 (1.00) EPHX2SMN1; SMN2ALDH1A1GAALMNA
SCHEMBL29334952 0.74 LMNA (0.65) EPHX2ALDH1A1GAALMNAMAPK1
SCHEMBL4184514 0.73 EPHX2 (0.51) EPHX2LMNAMAPK1NLRP1DDR1
SCHEMBL4192539 0.73 EPHX2 (0.63) EPHX2LMNAMAPK1NLRP1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors EPHX1, EPHX2, NCEH1 EPHX2 2/4885SMN1; SMN2 4349/4885ALDH1A1 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.